1343 related articles for article (PubMed ID: 32028981)
1. BRD7 suppresses invasion and metastasis in breast cancer by negatively regulating YB1-induced epithelial-mesenchymal transition.
Niu W; Luo Y; Zhou Y; Li M; Wu C; Duan Y; Wang H; Fan S; Li Z; Xiong W; Li X; Li G; Ren C; Li H; Zhou M
J Exp Clin Cancer Res; 2020 Feb; 39(1):30. PubMed ID: 32028981
[TBL] [Abstract][Full Text] [Related]
2. Long Non-Coding RNA (LncRNA) HOXA11-AS Promotes Breast Cancer Invasion and Metastasis by Regulating Epithelial-Mesenchymal Transition.
Li W; Jia G; Qu Y; Du Q; Liu B; Liu B
Med Sci Monit; 2017 Jul; 23():3393-3403. PubMed ID: 28701685
[TBL] [Abstract][Full Text] [Related]
3. UBE2C, Directly Targeted by miR-548e-5p, Increases the Cellular Growth and Invasive Abilities of Cancer Cells Interacting with the EMT Marker Protein Zinc Finger E-box Binding Homeobox 1/2 in NSCLC.
Jin D; Guo J; Wu Y; Du J; Wang X; An J; Hu B; Kong L; Di W; Wang W
Theranostics; 2019; 9(7):2036-2055. PubMed ID: 31037155
[No Abstract] [Full Text] [Related]
4. Knockdown of lncRNA GHET1 inhibits osteosarcoma cells proliferation, invasion, migration and EMT in vitro and in vivo.
Yang W; Shan Z; Zhou X; Peng L; Zhi C; Chai J; Liu H; Yang J; Zhang Z
Cancer Biomark; 2018; 23(4):589-601. PubMed ID: 30475755
[TBL] [Abstract][Full Text] [Related]
5. Long non-coding RNA GHET1 promotes human breast cancer cell proliferation, invasion and migration via affecting epithelial mesenchymal transition.
Song R; Zhang J; Huang J; Hai T
Cancer Biomark; 2018; 22(3):565-573. PubMed ID: 29843220
[TBL] [Abstract][Full Text] [Related]
6. Knockdown of lncRNA ZEB2NAT suppresses epithelial mesenchymal transition, metastasis and proliferation in breast cancer cells.
Eroğlu Güneş C; Güçlü E; Vural H; Kurar E
Gene; 2021 Dec; 805():145904. PubMed ID: 34418470
[TBL] [Abstract][Full Text] [Related]
7. Resveratrol Inhibits the Migration and Metastasis of MDA-MB-231 Human Breast Cancer by Reversing TGF-β1-Induced Epithelial-Mesenchymal Transition.
Sun Y; Zhou QM; Lu YY; Zhang H; Chen QL; Zhao M; Su SB
Molecules; 2019 Mar; 24(6):. PubMed ID: 30901941
[TBL] [Abstract][Full Text] [Related]
8. YB1 regulates miR-205/200b-ZEB1 axis by inhibiting microRNA maturation in hepatocellular carcinoma.
Liu X; Chen D; Chen H; Wang W; Liu Y; Wang Y; Duan C; Ning Z; Guo X; Otkur W; Liu J; Qi H; Liu X; Lin A; Xia T; Liu HX; Piao HL
Cancer Commun (Lond); 2021 Jul; 41(7):576-595. PubMed ID: 34110104
[TBL] [Abstract][Full Text] [Related]
9. Knockdown of Y‑box‑binding protein‑1 inhibits the malignant progression of HT‑29 colorectal adenocarcinoma cells by reversing epithelial‑mesenchymal transition.
Yan XB; Zhu QC; Chen HQ; Peng JY; Chao HL; Du HX; Wang ZG; Jin ZM
Mol Med Rep; 2014 Nov; 10(5):2720-8. PubMed ID: 25201740
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of lncRNA PANDAR reduces cell proliferation, cell invasion and suppresses EMT pathway in breast cancer.
Li Y; Su X; Pan H
Cancer Biomark; 2019; 25(2):185-192. PubMed ID: 31104011
[TBL] [Abstract][Full Text] [Related]
11. miR-485-5p inhibits the progression of breast cancer cells by negatively regulating MUC1.
Wang X; Zhou X; Zeng F; Wu X; Li H
Breast Cancer; 2020 Jul; 27(4):765-775. PubMed ID: 32144736
[TBL] [Abstract][Full Text] [Related]
12. LINC00511 contributes to glioblastoma tumorigenesis and epithelial-mesenchymal transition via LINC00511/miR-524-5p/YB1/ZEB1 positive feedback loop.
Du X; Tu Y; Liu S; Zhao P; Bao Z; Li C; Li J; Pan M; Ji J
J Cell Mol Med; 2020 Jan; 24(2):1474-1487. PubMed ID: 31856394
[TBL] [Abstract][Full Text] [Related]
13. Tumor-promoting properties of miR-8084 in breast cancer through enhancing proliferation, suppressing apoptosis and inducing epithelial-mesenchymal transition.
Gao Y; Ma H; Gao C; Lv Y; Chen X; Xu R; Sun M; Liu X; Lu X; Pei X; Li P
J Transl Med; 2018 Feb; 16(1):38. PubMed ID: 29471858
[TBL] [Abstract][Full Text] [Related]
14. High B3GALT5 expression confers poor clinical outcome and contributes to tumor progression and metastasis in breast cancer.
Liao YM; Wang YH; Hung JT; Lin YJ; Huang YL; Liao GS; Hsu YL; Wu JC; Yu AL
Breast Cancer Res; 2021 Jan; 23(1):5. PubMed ID: 33413566
[TBL] [Abstract][Full Text] [Related]
15. LincK contributes to breast tumorigenesis by promoting proliferation and epithelial-to-mesenchymal transition.
Li J; Hao Y; Mao W; Xue X; Xu P; Liu L; Yuan J; Zhang D; Li N; Chen H; Zhao L; Sun Z; Luo J; Chen R; Zhao RC
J Hematol Oncol; 2019 Feb; 12(1):19. PubMed ID: 30795783
[TBL] [Abstract][Full Text] [Related]
16. Epithelial requirement for in vitro proliferation and xenograft growth and metastasis of MDA-MB-468 human breast cancer cells: oncogenic rather than tumor-suppressive role of E-cadherin.
Hugo HJ; Gunasinghe NPAD; Hollier BG; Tanaka T; Blick T; Toh A; Hill P; Gilles C; Waltham M; Thompson EW
Breast Cancer Res; 2017 Jul; 19(1):86. PubMed ID: 28750639
[TBL] [Abstract][Full Text] [Related]
17. Cullin3 promotes breast cancer cells metastasis and epithelial-mesenchymal transition by targeting BRMS1 for degradation.
Huo X; Li S; Shi T; Suo A; Ruan Z; Guo H; Yao Y
Oncotarget; 2015 Dec; 6(39):41959-75. PubMed ID: 26544623
[TBL] [Abstract][Full Text] [Related]
18. IGJ suppresses breast cancer growth and metastasis by inhibiting EMT via the NF‑κB signaling pathway.
Wang M; Wu Y; Li X; Dai M; Li S
Int J Oncol; 2023 Sep; 63(3):. PubMed ID: 37539706
[TBL] [Abstract][Full Text] [Related]
19. miR-381 inhibited breast cancer cells proliferation, epithelial-to-mesenchymal transition and metastasis by targeting CXCR4.
Xue Y; Xu W; Zhao W; Wang W; Zhang D; Wu P
Biomed Pharmacother; 2017 Feb; 86():426-433. PubMed ID: 28012397
[TBL] [Abstract][Full Text] [Related]
20. Nimotuzumab inhibits epithelial-mesenchymal transition in prostate cancer by targeting the Akt/YB-1/AR axis.
Hu S; Duan YX; Zhou Q; Wang Y; Lu Q
IUBMB Life; 2019 Jul; 71(7):928-941. PubMed ID: 30907986
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
